Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock CaS-POL

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support. It is hypothesized that the treatment and outcome of cardiogenic shock, including mechanical circulatory support, are currently poor in Poland and should be improved. Unfortunately, without status quo data, efficient planning for its improvement cannot be conducted, hence the CaS-POL registry initiative.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E.

• age \> 18 years old

• persistent hemodynamic failure defined as systolic blood pressure of \<90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs

Locations
Other Locations
Poland
Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland
NOT_YET_RECRUITING
Wroclaw
Wroclaw Medical University
RECRUITING
Wroclaw
Contact Information
Primary
Wiktor Kuliczkowski, MD,PhD
wiktor.kuliczkowski@umw.edu.pl
+48 71 736 42 51
Backup
Mikołaj Błaziak, MD
blaziak.mikolaj@gmail.com
+48 71 736 42 51
Time Frame
Start Date: 2025-04-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 500
Treatments
cardiogenic shock patients
The registry will include all patients presenting with primary cardiogenic shock. All medical interventions will be conducted based on established clinical indications.
Related Therapeutic Areas
Sponsors
Collaborators: Polish Cardiac Society, Johnson & Johnson
Leads: Wroclaw Medical University

This content was sourced from clinicaltrials.gov